Renaissance Technologies (RenTech)'s BLFS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 207,128 shares of BioLife Solutions, Inc. (BLFS) worth $3.95 M, representing 0.01% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in BLFS, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 259,100 shares. Largest reduction occurred in Q2 2019, reducing 189,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s BioLife Solutions (BLFS) Holding Value Over Time
Track share changes against reported price movement
Quarterly BioLife Solutions (BLFS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -17,572 | Reduce 7.82% | 207,128 | $19.08 |
| Q4 2025 | +32,500 | Add 16.91% | 224,700 | $24.18 |
| Q3 2025 | -113,900 | Reduce 37.21% | 192,200 | $25.51 |
| Q2 2025 | +259,100 | Add 551.28% | 306,100 | $21.54 |
| Q1 2025 | +25,900 | Add 122.75% | 47,000 | $22.84 |
| Q4 2024 | -33,280 | Reduce 61.20% | 21,100 | $25.96 |
| Q3 2024 | +25,680 | Add 89.48% | 54,380 | $25.04 |
| Q2 2024 | +28,700 | New Buy | 28,700 | $21.43 |
| Q2 2023 | -34,300 | Sold Out | 0 | $0.00 |
| Q1 2023 | +34,300 | New Buy | 34,300 | $0.02 |
| Q3 2022 | -179,200 | Sold Out | 0 | $0.00 |
| Q2 2022 | +151,600 | Add 549.28% | 179,200 | $13.81 |
| Q1 2022 | +27,600 | New Buy | 27,600 | $22.72 |
| Q4 2021 | -66,600 | Sold Out | 0 | $0.00 |
| Q3 2021 | +66,600 | New Buy | 66,600 | $42.33 |
| Q2 2021 | -82,400 | Sold Out | 0 | $0.00 |
| Q1 2021 | +82,400 | New Buy | 82,400 | $36.00 |
| Q2 2020 | -39,200 | Sold Out | 0 | $0.00 |
| Q1 2020 | +8,946 | Add 29.57% | 39,200 | $9.49 |
| Q4 2019 | +14,954 | Add 97.74% | 30,254 | $16.20 |
| Q3 2019 | -105,300 | Reduce 87.31% | 15,300 | $16.60 |
| Q2 2019 | -189,300 | Reduce 61.08% | 120,600 | $16.95 |
| Q1 2019 | -133,600 | Reduce 30.12% | 309,900 | $17.89 |
| Q4 2018 | +15,600 | Add 3.65% | 443,500 | $12.03 |
| Q3 2018 | +221,000 | Add 106.81% | 427,900 | $17.50 |
| Q2 2018 | +179,100 | Add 644.24% | 206,900 | $11.41 |
| Q1 2018 | -9,799 | Reduce 26.06% | 27,800 | $5.14 |
| Q4 2017 | -49,301 | Reduce 56.73% | 37,599 | $6.01 |
| Q3 2017 | +86,900 | New Buy | 86,900 | $5.71 |
Renaissance Technologies (RenTech)'s BioLife Solutions Investment FAQs
Renaissance Technologies (RenTech) first purchased BioLife Solutions, Inc. (BLFS) in Q3 2017, acquiring 86,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held BioLife Solutions, Inc. (BLFS) for 29 quarters since Q3 2017.
Renaissance Technologies (RenTech)'s largest addition to BioLife Solutions, Inc. (BLFS) was in Q2 2025, adding 306,100 shares worth $6.59 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 207,128 shares of BioLife Solutions, Inc. (BLFS), valued at approximately $3.95 M.
As of the Q1 2026 filing, BioLife Solutions, Inc. (BLFS) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in BioLife Solutions, Inc. (BLFS) was 443,500 shares, as reported at the end of Q4 2018.